Results 241 to 250 of about 199,199 (290)

Tolerability and efficacy of chemosaturation in combination with systemic therapy for metastatic uveal melanoma

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Uveal melanoma is the most common primary intraocular cancer in adults, and up to half of patients develop metastatic disease, predominantly in the liver, where prognosis remains poor despite promising treatment options. In this study, the authors evaluated the safety and efficacy of administering systemic therapy within 40 days of liver ...
Patrick Kasteleiner   +4 more
wiley   +1 more source

Obstetrics and gynecology devices designed for low‐ and middle‐income countries: A narrative review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 71-80, April 2025.
Abstract There are many barriers contributing to poor health outcomes for women in low‐ and middle‐income countries (LMICs), one of which is the lack of necessary medical devices. Presently, the development of various kinds of devices intended to improve women's health outcomes specifically in LMICs remains underrepresented in the literature; therefore,
Dhanalakshmi Thiyagarajan   +2 more
wiley   +1 more source

Hysterectomy for placenta accreta spectrum disorder: Impact of institutional surgical volume on patient outcomes

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate trends in hysterectomy case volume for placenta accreta spectrum (PAS) disorder over time and compare maternal outcomes between high‐ and low‐volume centers. Specifically, we examined whether surgical volume influences severe maternal morbidity (SMM) and other key perioperative outcomes.
Lacey C. Brennan   +9 more
wiley   +1 more source

The effect of computer guided total hip replacement on risk of revision, Oxford Hip Score, and health related quality of life: an analysis of National Joint Registry data. [PDF]

open access: yesEur J Orthop Surg Traumatol
Farhan-Alanie MM   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy